Anti-Rab11A antibody

• WB

Project5428****

Western blot - Anti-Rab11A antibody (AB65200)

We believe that the additional bands observed at 45 and 72 kDa may be a result of disulphide-linked forms of the Rab11 protein

All lanes:

Western blot - Anti-Rab11A antibody (ab65200) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Lane 3:

MCF7 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg

Lane 4:

SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 24 kDa

Observed band size: 24 kDa,26 kDa,45 kDa,72 kDa

false

• WB

CiteAb

Western blot - Anti-Rab11A antibody (AB65200)

Rab11A western blot using anti-Rab11A antibody ab65200. Publication image and figure legend from Konitsiotis, A. D., Rossmannek, L., et al., 2017, Nat Commun, PubMed 28740133.

ab65200 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab65200 please see the product overview.

Steady-state PM localisation of Src and Fyn requires vesicular traffic from the RE and Golgi. a Confocal images showing the steady-state localisation of mCitrine fused Src and Fyn in HeLa cells co-expressing the PM marker mCh-tK-Ras, and stained with antibodies against the RE compartment marker, Rab11a (see also Supplementary Fig. 2a). Dot plot depicts Pearson’s correlation coefficient for Src and Fyn with either the PM marker or the RE marker (n > 60 cells per condition from two independent experiments, data are mean ± SD). b HeLa cells co-expressing the dominant-negative mutant form of Rab11 (Rab11S25N-BFP) and either Src-mCit or Fyn-mCit (see also Supplementary Fig. 2b). Dot plot depicts the percentage of the area of Src or Fyn pixels staining internal membrane structures that overlapped with the Rab11S25N-BFP pixels (n > 40 cells per condition, data are mean ± SD, ****P < 0.0001, Student’s t-test). c Confocal micrographs of HeLa cells expressing Src-mCit and Fyn-mCit, transfected with Rab11a/b targeting siRNA or non-targeting siRNA control nucleotides. d Representative western blot showing Rab11a levels of transfected cells and the Tubulin-loading control (n = 3 independent experiments). e HeLa cells co-expressing the Golgi marker (GalT-mCer) and Src-mCit or Fyn-mCit, either cultured at 37 °C (left panels) or 20 °C (right panels) for 24 h, at which point cells were fixed. Graph depicts the percentage of the area of Src or Fyn pixels staining internal membrane structures that overlapped with the GalT-mCer pixels (n > 40 cells for each condition from two independent experiments, data are depicted as a box and whiskers plot, showing the median and the full range of the measurements. ***P < 0.001; ****P < 0.0001; n.s., not significant, as determined by Student’s t-test). f Time series of HeLa cells co-expressing the Golgi marker (GalT-mCer) and Fyn-mCit, treated with the 25 μM of the APT inhibitor palmostatin-M (Pal). The plot to the right depict the integrated intensity of Fyn-mCit at the Golgi over the integrated intensity over the whole of the cell (n = 17 cells from two independent experiments; data are mean ± SEM). Scale bars, 10 μm

false